✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Here, we present the first case report to demonstrate rhabdomylysis secondary to diclofenac administration.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Diclofenac, a widely used nonsteroidal anti-inflammatory drug, has been reported to cause fatal drug-induced rhabdomyolysis very rarely .
📊
Key Findings & Data:We report a case of a 13-month-old girl who developed fatal rhabdomyolysis after administration of intramuscular diclofenac for relief of pain caused by a scalding burn injury.
💡
Conclusion & Impact:Here, we present the first case report to demonstrate rhabdomylysis secondary to diclofenac administration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Rhabdomyolysis · diclofenac · child
Abstract
Diclofenac, a widely used nonsteroidal anti-inflammatory drug, has been reported to cause fatal drug-induced rhabdomyolysis very rarely . We report a case of a 13-month-old girl who developed fatal rhabdomyolysis after administration of intramuscular diclofenac for relief of pain caused by a scalding burn injury. Rhabdomyolysis due to diclofenac has not been reported in children. Here, we present the first case report to demonstrate rhabdomylysis secondary to diclofenac administration.
🔖
Cite This Article
Güzel, A., Biner, B. O., Aylanç, H., Karasalihoğlu, S. (2011). Fatal Acute Diclofenac-Induced Rhabdomyolysis in A Pediatric Patient. Balkan Medical Journal, Cilt: 2011 Sayı: 1, 102–103. https://doi.org/10.5174/tutfd.2009.02192.0